nodes	percent_of_prediction	percent_of_DWPC	metapath
Tadalafil—CYP3A4—Thiotepa—sarcoma	0.168	0.458	CbGbCtD
Tadalafil—CYP3A4—Mitoxantrone—sarcoma	0.0724	0.197	CbGbCtD
Tadalafil—CYP3A4—Vincristine—sarcoma	0.0498	0.136	CbGbCtD
Tadalafil—PDE5A—pulmonary artery—sarcoma	0.0472	0.361	CbGeAlD
Tadalafil—CYP3A4—Etoposide—sarcoma	0.0457	0.124	CbGbCtD
Tadalafil—CYP3A4—Doxorubicin—sarcoma	0.0312	0.0848	CbGbCtD
Tadalafil—PDE5A—endothelium—sarcoma	0.0148	0.113	CbGeAlD
Tadalafil—PDE11A—tendon—sarcoma	0.0126	0.0966	CbGeAlD
Tadalafil—PDE11A—testis—sarcoma	0.0104	0.08	CbGeAlD
Tadalafil—PDE11A—liver—sarcoma	0.00987	0.0756	CbGeAlD
Tadalafil—PDE5A—hematopoietic system—sarcoma	0.00725	0.0555	CbGeAlD
Tadalafil—PDE5A—connective tissue—sarcoma	0.00698	0.0535	CbGeAlD
Tadalafil—PDE5A—smooth muscle tissue—sarcoma	0.00639	0.0489	CbGeAlD
Tadalafil—PDE5A—tendon—sarcoma	0.0048	0.0368	CbGeAlD
Tadalafil—PDE5A—testis—sarcoma	0.00397	0.0304	CbGeAlD
Tadalafil—PDE5A—lymph node—sarcoma	0.00288	0.0221	CbGeAlD
Tadalafil—CYP3A4—hematopoietic system—sarcoma	0.00226	0.0173	CbGeAlD
Tadalafil—CYP3A4—liver—sarcoma	0.00117	0.00897	CbGeAlD
Tadalafil—Somnolence—Mitoxantrone—sarcoma	0.00101	0.00201	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Vincristine—sarcoma	0.00101	0.00201	CcSEcCtD
Tadalafil—Fatigue—Vincristine—sarcoma	0.00101	0.002	CcSEcCtD
Tadalafil—Convulsion—Etoposide—sarcoma	0.001	0.002	CcSEcCtD
Tadalafil—Dyspepsia—Mitoxantrone—sarcoma	0.001	0.00199	CcSEcCtD
Tadalafil—Hypertension—Etoposide—sarcoma	0.000999	0.00199	CcSEcCtD
Tadalafil—Pain—Vincristine—sarcoma	0.000997	0.00199	CcSEcCtD
Tadalafil—Constipation—Vincristine—sarcoma	0.000997	0.00199	CcSEcCtD
Tadalafil—Pain in extremity—Doxorubicin—sarcoma	0.000997	0.00199	CcSEcCtD
Tadalafil—Liver function test abnormal—Epirubicin—sarcoma	0.000995	0.00198	CcSEcCtD
Tadalafil—Chest pain—Etoposide—sarcoma	0.000985	0.00196	CcSEcCtD
Tadalafil—Orthostatic hypotension—Epirubicin—sarcoma	0.000984	0.00196	CcSEcCtD
Tadalafil—Abdominal pain upper—Epirubicin—sarcoma	0.000984	0.00196	CcSEcCtD
Tadalafil—Migraine—Doxorubicin—sarcoma	0.000981	0.00195	CcSEcCtD
Tadalafil—Fatigue—Mitoxantrone—sarcoma	0.000979	0.00195	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000979	0.00195	CcSEcCtD
Tadalafil—Discomfort—Etoposide—sarcoma	0.000973	0.00194	CcSEcCtD
Tadalafil—Breast disorder—Epirubicin—sarcoma	0.000973	0.00194	CcSEcCtD
Tadalafil—Constipation—Mitoxantrone—sarcoma	0.000971	0.00193	CcSEcCtD
Tadalafil—Pain—Mitoxantrone—sarcoma	0.000971	0.00193	CcSEcCtD
Tadalafil—Hypersensitivity—Thiotepa—sarcoma	0.000969	0.00193	CcSEcCtD
Tadalafil—Nasopharyngitis—Epirubicin—sarcoma	0.000963	0.00192	CcSEcCtD
Tadalafil—Face oedema—Doxorubicin—sarcoma	0.000962	0.00192	CcSEcCtD
Tadalafil—Hypersensitivity—Dactinomycin—sarcoma	0.000962	0.00192	CcSEcCtD
Tadalafil—Gastrointestinal pain—Vincristine—sarcoma	0.000953	0.0019	CcSEcCtD
Tadalafil—Gastritis—Epirubicin—sarcoma	0.000953	0.0019	CcSEcCtD
Tadalafil—Asthenia—Thiotepa—sarcoma	0.000943	0.00188	CcSEcCtD
Tadalafil—Infection—Etoposide—sarcoma	0.000938	0.00187	CcSEcCtD
Tadalafil—Asthenia—Dactinomycin—sarcoma	0.000936	0.00187	CcSEcCtD
Tadalafil—Influenza—Epirubicin—sarcoma	0.000931	0.00185	CcSEcCtD
Tadalafil—Dysphagia—Epirubicin—sarcoma	0.000931	0.00185	CcSEcCtD
Tadalafil—Pruritus—Thiotepa—sarcoma	0.00093	0.00185	CcSEcCtD
Tadalafil—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000929	0.00185	CcSEcCtD
Tadalafil—Tachycardia—Etoposide—sarcoma	0.000922	0.00184	CcSEcCtD
Tadalafil—Abdominal pain—Vincristine—sarcoma	0.000922	0.00184	CcSEcCtD
Tadalafil—Liver function test abnormal—Doxorubicin—sarcoma	0.00092	0.00183	CcSEcCtD
Tadalafil—Skin disorder—Etoposide—sarcoma	0.000917	0.00183	CcSEcCtD
Tadalafil—Hyperhidrosis—Etoposide—sarcoma	0.000913	0.00182	CcSEcCtD
Tadalafil—Abdominal pain upper—Doxorubicin—sarcoma	0.00091	0.00181	CcSEcCtD
Tadalafil—Orthostatic hypotension—Doxorubicin—sarcoma	0.00091	0.00181	CcSEcCtD
Tadalafil—Angina pectoris—Epirubicin—sarcoma	0.000907	0.00181	CcSEcCtD
Tadalafil—Urticaria—Mitoxantrone—sarcoma	0.000902	0.0018	CcSEcCtD
Tadalafil—Breast disorder—Doxorubicin—sarcoma	0.000901	0.00179	CcSEcCtD
Tadalafil—Diarrhoea—Thiotepa—sarcoma	0.0009	0.00179	CcSEcCtD
Tadalafil—Abdominal pain—Mitoxantrone—sarcoma	0.000898	0.00179	CcSEcCtD
Tadalafil—Bronchitis—Epirubicin—sarcoma	0.000895	0.00178	CcSEcCtD
Tadalafil—Diarrhoea—Dactinomycin—sarcoma	0.000893	0.00178	CcSEcCtD
Tadalafil—Nasopharyngitis—Doxorubicin—sarcoma	0.000891	0.00178	CcSEcCtD
Tadalafil—Hypotension—Etoposide—sarcoma	0.000883	0.00176	CcSEcCtD
Tadalafil—Gastritis—Doxorubicin—sarcoma	0.000882	0.00176	CcSEcCtD
Tadalafil—Dizziness—Thiotepa—sarcoma	0.00087	0.00173	CcSEcCtD
Tadalafil—Upper respiratory tract infection—Epirubicin—sarcoma	0.000865	0.00172	CcSEcCtD
Tadalafil—Dysphagia—Doxorubicin—sarcoma	0.000861	0.00172	CcSEcCtD
Tadalafil—Influenza—Doxorubicin—sarcoma	0.000861	0.00172	CcSEcCtD
Tadalafil—Hypersensitivity—Vincristine—sarcoma	0.000859	0.00171	CcSEcCtD
Tadalafil—Paraesthesia—Etoposide—sarcoma	0.000848	0.00169	CcSEcCtD
Tadalafil—Dyspnoea—Etoposide—sarcoma	0.000842	0.00168	CcSEcCtD
Tadalafil—Somnolence—Etoposide—sarcoma	0.00084	0.00167	CcSEcCtD
Tadalafil—Angina pectoris—Doxorubicin—sarcoma	0.000839	0.00167	CcSEcCtD
Tadalafil—Hypersensitivity—Mitoxantrone—sarcoma	0.000837	0.00167	CcSEcCtD
Tadalafil—Asthenia—Vincristine—sarcoma	0.000837	0.00167	CcSEcCtD
Tadalafil—Vomiting—Thiotepa—sarcoma	0.000836	0.00167	CcSEcCtD
Tadalafil—Infestation—Epirubicin—sarcoma	0.00083	0.00165	CcSEcCtD
Tadalafil—Infestation NOS—Epirubicin—sarcoma	0.00083	0.00165	CcSEcCtD
Tadalafil—Vomiting—Dactinomycin—sarcoma	0.00083	0.00165	CcSEcCtD
Tadalafil—Rash—Thiotepa—sarcoma	0.000829	0.00165	CcSEcCtD
Tadalafil—Bronchitis—Doxorubicin—sarcoma	0.000829	0.00165	CcSEcCtD
Tadalafil—Dermatitis—Thiotepa—sarcoma	0.000828	0.00165	CcSEcCtD
Tadalafil—Headache—Thiotepa—sarcoma	0.000824	0.00164	CcSEcCtD
Tadalafil—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000823	0.00164	CcSEcCtD
Tadalafil—Rash—Dactinomycin—sarcoma	0.000823	0.00164	CcSEcCtD
Tadalafil—Renal failure—Epirubicin—sarcoma	0.000816	0.00163	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Etoposide—sarcoma	0.000815	0.00162	CcSEcCtD
Tadalafil—Asthenia—Mitoxantrone—sarcoma	0.000815	0.00162	CcSEcCtD
Tadalafil—Fatigue—Etoposide—sarcoma	0.000814	0.00162	CcSEcCtD
Tadalafil—Pain—Etoposide—sarcoma	0.000808	0.00161	CcSEcCtD
Tadalafil—Constipation—Etoposide—sarcoma	0.000808	0.00161	CcSEcCtD
Tadalafil—Conjunctivitis—Epirubicin—sarcoma	0.000807	0.00161	CcSEcCtD
Tadalafil—Urinary tract infection—Epirubicin—sarcoma	0.000807	0.00161	CcSEcCtD
Tadalafil—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000801	0.00159	CcSEcCtD
Tadalafil—Diarrhoea—Vincristine—sarcoma	0.000798	0.00159	CcSEcCtD
Tadalafil—Sweating—Epirubicin—sarcoma	0.000796	0.00159	CcSEcCtD
Tadalafil—Haematuria—Epirubicin—sarcoma	0.000792	0.00158	CcSEcCtD
Tadalafil—Epistaxis—Epirubicin—sarcoma	0.000783	0.00156	CcSEcCtD
Tadalafil—Nausea—Thiotepa—sarcoma	0.000781	0.00156	CcSEcCtD
Tadalafil—Diarrhoea—Mitoxantrone—sarcoma	0.000777	0.00155	CcSEcCtD
Tadalafil—Nausea—Dactinomycin—sarcoma	0.000775	0.00154	CcSEcCtD
Tadalafil—Gastrointestinal pain—Etoposide—sarcoma	0.000772	0.00154	CcSEcCtD
Tadalafil—Dizziness—Vincristine—sarcoma	0.000771	0.00154	CcSEcCtD
Tadalafil—Infestation NOS—Doxorubicin—sarcoma	0.000768	0.00153	CcSEcCtD
Tadalafil—Infestation—Doxorubicin—sarcoma	0.000768	0.00153	CcSEcCtD
Tadalafil—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000762	0.00152	CcSEcCtD
Tadalafil—Renal failure—Doxorubicin—sarcoma	0.000755	0.0015	CcSEcCtD
Tadalafil—Urticaria—Etoposide—sarcoma	0.00075	0.00149	CcSEcCtD
Tadalafil—Haemoglobin—Epirubicin—sarcoma	0.000749	0.00149	CcSEcCtD
Tadalafil—Rhinitis—Epirubicin—sarcoma	0.000747	0.00149	CcSEcCtD
Tadalafil—Abdominal pain—Etoposide—sarcoma	0.000747	0.00149	CcSEcCtD
Tadalafil—Urinary tract infection—Doxorubicin—sarcoma	0.000747	0.00149	CcSEcCtD
Tadalafil—Conjunctivitis—Doxorubicin—sarcoma	0.000747	0.00149	CcSEcCtD
Tadalafil—Haemorrhage—Epirubicin—sarcoma	0.000745	0.00148	CcSEcCtD
Tadalafil—Hypoaesthesia—Epirubicin—sarcoma	0.000741	0.00148	CcSEcCtD
Tadalafil—Vomiting—Vincristine—sarcoma	0.000741	0.00148	CcSEcCtD
Tadalafil—Pharyngitis—Epirubicin—sarcoma	0.00074	0.00147	CcSEcCtD
Tadalafil—Sweating—Doxorubicin—sarcoma	0.000736	0.00147	CcSEcCtD
Tadalafil—Urinary tract disorder—Epirubicin—sarcoma	0.000736	0.00147	CcSEcCtD
Tadalafil—Rash—Vincristine—sarcoma	0.000735	0.00146	CcSEcCtD
Tadalafil—Dermatitis—Vincristine—sarcoma	0.000735	0.00146	CcSEcCtD
Tadalafil—Oedema peripheral—Epirubicin—sarcoma	0.000734	0.00146	CcSEcCtD
Tadalafil—Haematuria—Doxorubicin—sarcoma	0.000732	0.00146	CcSEcCtD
Tadalafil—Connective tissue disorder—Epirubicin—sarcoma	0.000732	0.00146	CcSEcCtD
Tadalafil—Urethral disorder—Epirubicin—sarcoma	0.000731	0.00146	CcSEcCtD
Tadalafil—Headache—Vincristine—sarcoma	0.00073	0.00146	CcSEcCtD
Tadalafil—Epistaxis—Doxorubicin—sarcoma	0.000725	0.00144	CcSEcCtD
Tadalafil—Vomiting—Mitoxantrone—sarcoma	0.000722	0.00144	CcSEcCtD
Tadalafil—Rash—Mitoxantrone—sarcoma	0.000716	0.00143	CcSEcCtD
Tadalafil—Dermatitis—Mitoxantrone—sarcoma	0.000715	0.00142	CcSEcCtD
Tadalafil—Headache—Mitoxantrone—sarcoma	0.000711	0.00142	CcSEcCtD
Tadalafil—Erythema multiforme—Epirubicin—sarcoma	0.000705	0.0014	CcSEcCtD
Tadalafil—Eye disorder—Epirubicin—sarcoma	0.000696	0.00139	CcSEcCtD
Tadalafil—Hypersensitivity—Etoposide—sarcoma	0.000696	0.00139	CcSEcCtD
Tadalafil—Tinnitus—Epirubicin—sarcoma	0.000695	0.00138	CcSEcCtD
Tadalafil—Haemoglobin—Doxorubicin—sarcoma	0.000693	0.00138	CcSEcCtD
Tadalafil—Nausea—Vincristine—sarcoma	0.000693	0.00138	CcSEcCtD
Tadalafil—Cardiac disorder—Epirubicin—sarcoma	0.000692	0.00138	CcSEcCtD
Tadalafil—Flushing—Epirubicin—sarcoma	0.000692	0.00138	CcSEcCtD
Tadalafil—Rhinitis—Doxorubicin—sarcoma	0.000691	0.00138	CcSEcCtD
Tadalafil—Haemorrhage—Doxorubicin—sarcoma	0.00069	0.00137	CcSEcCtD
Tadalafil—Hypoaesthesia—Doxorubicin—sarcoma	0.000686	0.00137	CcSEcCtD
Tadalafil—Pharyngitis—Doxorubicin—sarcoma	0.000684	0.00136	CcSEcCtD
Tadalafil—Urinary tract disorder—Doxorubicin—sarcoma	0.000681	0.00136	CcSEcCtD
Tadalafil—Oedema peripheral—Doxorubicin—sarcoma	0.000679	0.00135	CcSEcCtD
Tadalafil—Asthenia—Etoposide—sarcoma	0.000678	0.00135	CcSEcCtD
Tadalafil—Connective tissue disorder—Doxorubicin—sarcoma	0.000678	0.00135	CcSEcCtD
Tadalafil—Angiopathy—Epirubicin—sarcoma	0.000676	0.00135	CcSEcCtD
Tadalafil—Urethral disorder—Doxorubicin—sarcoma	0.000676	0.00135	CcSEcCtD
Tadalafil—Nausea—Mitoxantrone—sarcoma	0.000674	0.00134	CcSEcCtD
Tadalafil—Immune system disorder—Epirubicin—sarcoma	0.000673	0.00134	CcSEcCtD
Tadalafil—Mediastinal disorder—Epirubicin—sarcoma	0.000672	0.00134	CcSEcCtD
Tadalafil—Pruritus—Etoposide—sarcoma	0.000668	0.00133	CcSEcCtD
Tadalafil—Mental disorder—Epirubicin—sarcoma	0.000653	0.0013	CcSEcCtD
Tadalafil—Erythema multiforme—Doxorubicin—sarcoma	0.000652	0.0013	CcSEcCtD
Tadalafil—Diarrhoea—Etoposide—sarcoma	0.000646	0.00129	CcSEcCtD
Tadalafil—Eye disorder—Doxorubicin—sarcoma	0.000644	0.00128	CcSEcCtD
Tadalafil—Tinnitus—Doxorubicin—sarcoma	0.000643	0.00128	CcSEcCtD
Tadalafil—Flushing—Doxorubicin—sarcoma	0.00064	0.00127	CcSEcCtD
Tadalafil—Cardiac disorder—Doxorubicin—sarcoma	0.00064	0.00127	CcSEcCtD
Tadalafil—Back pain—Epirubicin—sarcoma	0.000628	0.00125	CcSEcCtD
Tadalafil—Angiopathy—Doxorubicin—sarcoma	0.000626	0.00125	CcSEcCtD
Tadalafil—Dizziness—Etoposide—sarcoma	0.000625	0.00124	CcSEcCtD
Tadalafil—Muscle spasms—Epirubicin—sarcoma	0.000624	0.00124	CcSEcCtD
Tadalafil—Immune system disorder—Doxorubicin—sarcoma	0.000623	0.00124	CcSEcCtD
Tadalafil—Mediastinal disorder—Doxorubicin—sarcoma	0.000621	0.00124	CcSEcCtD
Tadalafil—Vision blurred—Epirubicin—sarcoma	0.000611	0.00122	CcSEcCtD
Tadalafil—Mental disorder—Doxorubicin—sarcoma	0.000604	0.0012	CcSEcCtD
Tadalafil—Vomiting—Etoposide—sarcoma	0.000601	0.0012	CcSEcCtD
Tadalafil—Rash—Etoposide—sarcoma	0.000596	0.00119	CcSEcCtD
Tadalafil—Dermatitis—Etoposide—sarcoma	0.000595	0.00119	CcSEcCtD
Tadalafil—Headache—Etoposide—sarcoma	0.000592	0.00118	CcSEcCtD
Tadalafil—Vertigo—Epirubicin—sarcoma	0.000583	0.00116	CcSEcCtD
Tadalafil—Syncope—Epirubicin—sarcoma	0.000582	0.00116	CcSEcCtD
Tadalafil—Back pain—Doxorubicin—sarcoma	0.000581	0.00116	CcSEcCtD
Tadalafil—Muscle spasms—Doxorubicin—sarcoma	0.000577	0.00115	CcSEcCtD
Tadalafil—Palpitations—Epirubicin—sarcoma	0.000573	0.00114	CcSEcCtD
Tadalafil—Loss of consciousness—Epirubicin—sarcoma	0.00057	0.00114	CcSEcCtD
Tadalafil—Cough—Epirubicin—sarcoma	0.000566	0.00113	CcSEcCtD
Tadalafil—Vision blurred—Doxorubicin—sarcoma	0.000566	0.00113	CcSEcCtD
Tadalafil—Convulsion—Epirubicin—sarcoma	0.000562	0.00112	CcSEcCtD
Tadalafil—Nausea—Etoposide—sarcoma	0.000561	0.00112	CcSEcCtD
Tadalafil—Hypertension—Epirubicin—sarcoma	0.00056	0.00112	CcSEcCtD
Tadalafil—Chest pain—Epirubicin—sarcoma	0.000552	0.0011	CcSEcCtD
Tadalafil—Myalgia—Epirubicin—sarcoma	0.000552	0.0011	CcSEcCtD
Tadalafil—Arthralgia—Epirubicin—sarcoma	0.000552	0.0011	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000549	0.00109	CcSEcCtD
Tadalafil—Discomfort—Epirubicin—sarcoma	0.000546	0.00109	CcSEcCtD
Tadalafil—Dry mouth—Epirubicin—sarcoma	0.00054	0.00108	CcSEcCtD
Tadalafil—Vertigo—Doxorubicin—sarcoma	0.000539	0.00107	CcSEcCtD
Tadalafil—Syncope—Doxorubicin—sarcoma	0.000538	0.00107	CcSEcCtD
Tadalafil—Palpitations—Doxorubicin—sarcoma	0.00053	0.00106	CcSEcCtD
Tadalafil—Oedema—Epirubicin—sarcoma	0.000529	0.00105	CcSEcCtD
Tadalafil—Loss of consciousness—Doxorubicin—sarcoma	0.000528	0.00105	CcSEcCtD
Tadalafil—Infection—Epirubicin—sarcoma	0.000526	0.00105	CcSEcCtD
Tadalafil—Cough—Doxorubicin—sarcoma	0.000524	0.00104	CcSEcCtD
Tadalafil—Shock—Epirubicin—sarcoma	0.000521	0.00104	CcSEcCtD
Tadalafil—Convulsion—Doxorubicin—sarcoma	0.00052	0.00104	CcSEcCtD
Tadalafil—Nervous system disorder—Epirubicin—sarcoma	0.000519	0.00103	CcSEcCtD
Tadalafil—Hypertension—Doxorubicin—sarcoma	0.000518	0.00103	CcSEcCtD
Tadalafil—Tachycardia—Epirubicin—sarcoma	0.000517	0.00103	CcSEcCtD
Tadalafil—Skin disorder—Epirubicin—sarcoma	0.000514	0.00102	CcSEcCtD
Tadalafil—Hyperhidrosis—Epirubicin—sarcoma	0.000512	0.00102	CcSEcCtD
Tadalafil—Arthralgia—Doxorubicin—sarcoma	0.000511	0.00102	CcSEcCtD
Tadalafil—Myalgia—Doxorubicin—sarcoma	0.000511	0.00102	CcSEcCtD
Tadalafil—Chest pain—Doxorubicin—sarcoma	0.000511	0.00102	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000508	0.00101	CcSEcCtD
Tadalafil—Discomfort—Doxorubicin—sarcoma	0.000505	0.00101	CcSEcCtD
Tadalafil—Dry mouth—Doxorubicin—sarcoma	0.0005	0.000996	CcSEcCtD
Tadalafil—Hypotension—Epirubicin—sarcoma	0.000495	0.000985	CcSEcCtD
Tadalafil—Oedema—Doxorubicin—sarcoma	0.00049	0.000976	CcSEcCtD
Tadalafil—Infection—Doxorubicin—sarcoma	0.000487	0.000969	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000482	0.000961	CcSEcCtD
Tadalafil—Shock—Doxorubicin—sarcoma	0.000482	0.00096	CcSEcCtD
Tadalafil—Nervous system disorder—Doxorubicin—sarcoma	0.00048	0.000957	CcSEcCtD
Tadalafil—Insomnia—Epirubicin—sarcoma	0.000479	0.000954	CcSEcCtD
Tadalafil—Tachycardia—Doxorubicin—sarcoma	0.000478	0.000952	CcSEcCtD
Tadalafil—Skin disorder—Doxorubicin—sarcoma	0.000476	0.000948	CcSEcCtD
Tadalafil—Paraesthesia—Epirubicin—sarcoma	0.000475	0.000947	CcSEcCtD
Tadalafil—Hyperhidrosis—Doxorubicin—sarcoma	0.000474	0.000943	CcSEcCtD
Tadalafil—Dyspnoea—Epirubicin—sarcoma	0.000472	0.00094	CcSEcCtD
Tadalafil—Somnolence—Epirubicin—sarcoma	0.000471	0.000938	CcSEcCtD
Tadalafil—Dyspepsia—Epirubicin—sarcoma	0.000466	0.000928	CcSEcCtD
Tadalafil—Hypotension—Doxorubicin—sarcoma	0.000458	0.000912	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Epirubicin—sarcoma	0.000457	0.000911	CcSEcCtD
Tadalafil—Fatigue—Epirubicin—sarcoma	0.000456	0.000909	CcSEcCtD
Tadalafil—Constipation—Epirubicin—sarcoma	0.000453	0.000902	CcSEcCtD
Tadalafil—Pain—Epirubicin—sarcoma	0.000453	0.000902	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000446	0.000889	CcSEcCtD
Tadalafil—Insomnia—Doxorubicin—sarcoma	0.000443	0.000883	CcSEcCtD
Tadalafil—Paraesthesia—Doxorubicin—sarcoma	0.00044	0.000876	CcSEcCtD
Tadalafil—Dyspnoea—Doxorubicin—sarcoma	0.000437	0.00087	CcSEcCtD
Tadalafil—Somnolence—Doxorubicin—sarcoma	0.000436	0.000868	CcSEcCtD
Tadalafil—Gastrointestinal pain—Epirubicin—sarcoma	0.000433	0.000862	CcSEcCtD
Tadalafil—Dyspepsia—Doxorubicin—sarcoma	0.000431	0.000859	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000423	0.000842	CcSEcCtD
Tadalafil—Fatigue—Doxorubicin—sarcoma	0.000422	0.000841	CcSEcCtD
Tadalafil—Urticaria—Epirubicin—sarcoma	0.000421	0.000838	CcSEcCtD
Tadalafil—Constipation—Doxorubicin—sarcoma	0.000419	0.000834	CcSEcCtD
Tadalafil—Pain—Doxorubicin—sarcoma	0.000419	0.000834	CcSEcCtD
Tadalafil—Abdominal pain—Epirubicin—sarcoma	0.000419	0.000834	CcSEcCtD
Tadalafil—Gastrointestinal pain—Doxorubicin—sarcoma	0.000401	0.000798	CcSEcCtD
Tadalafil—Hypersensitivity—Epirubicin—sarcoma	0.00039	0.000777	CcSEcCtD
Tadalafil—Urticaria—Doxorubicin—sarcoma	0.000389	0.000775	CcSEcCtD
Tadalafil—Abdominal pain—Doxorubicin—sarcoma	0.000387	0.000771	CcSEcCtD
Tadalafil—Asthenia—Epirubicin—sarcoma	0.00038	0.000757	CcSEcCtD
Tadalafil—Pruritus—Epirubicin—sarcoma	0.000375	0.000746	CcSEcCtD
Tadalafil—Diarrhoea—Epirubicin—sarcoma	0.000362	0.000722	CcSEcCtD
Tadalafil—Hypersensitivity—Doxorubicin—sarcoma	0.000361	0.000719	CcSEcCtD
Tadalafil—Asthenia—Doxorubicin—sarcoma	0.000351	0.0007	CcSEcCtD
Tadalafil—Dizziness—Epirubicin—sarcoma	0.00035	0.000697	CcSEcCtD
Tadalafil—Pruritus—Doxorubicin—sarcoma	0.000347	0.00069	CcSEcCtD
Tadalafil—Vomiting—Epirubicin—sarcoma	0.000337	0.000671	CcSEcCtD
Tadalafil—Diarrhoea—Doxorubicin—sarcoma	0.000335	0.000668	CcSEcCtD
Tadalafil—Rash—Epirubicin—sarcoma	0.000334	0.000665	CcSEcCtD
Tadalafil—Dermatitis—Epirubicin—sarcoma	0.000334	0.000664	CcSEcCtD
Tadalafil—Headache—Epirubicin—sarcoma	0.000332	0.000661	CcSEcCtD
Tadalafil—Dizziness—Doxorubicin—sarcoma	0.000324	0.000645	CcSEcCtD
Tadalafil—Nausea—Epirubicin—sarcoma	0.000314	0.000626	CcSEcCtD
Tadalafil—Vomiting—Doxorubicin—sarcoma	0.000311	0.00062	CcSEcCtD
Tadalafil—Rash—Doxorubicin—sarcoma	0.000309	0.000615	CcSEcCtD
Tadalafil—Dermatitis—Doxorubicin—sarcoma	0.000309	0.000615	CcSEcCtD
Tadalafil—Headache—Doxorubicin—sarcoma	0.000307	0.000611	CcSEcCtD
Tadalafil—Nausea—Doxorubicin—sarcoma	0.000291	0.00058	CcSEcCtD
